Wei Li

Title: Innovations in Obesity Treatment by Wei Li

Introduction

Wei Li is an accomplished inventor based in Huntington, WV (US). He has made significant contributions to the field of medical treatments, particularly in addressing obesity, atherosclerosis, and thrombosis. His innovative approaches have the potential to improve the quality of life for many individuals suffering from these conditions.

Latest Patents

Wei Li holds a patent for "Methods for treatment of obesity, atherosclerosis, and thrombosis." This patent outlines methods for treating these conditions by reducing the expression level or activity of thymidine phosphorylase in a subject in need. The treatment can involve administering an effective amount of a thymidine phosphorylase inhibitor, such as tipiracil, either alone or in combination with other therapeutic agents, including tissue plasminogen activator and aspirin. This innovative approach highlights the potential for targeted therapies in managing complex health issues.

Career Highlights

Wei Li is associated with the Marshall University Research Corporation, where he continues to explore and develop new methods for treating various health conditions. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative research.

Conclusion

Wei Li's contributions to the field of medical treatment, particularly in obesity and related conditions, demonstrate the importance of innovation in healthcare. His patent reflects a significant step forward in developing effective therapies that can benefit many patients.